Merck Sees $1.9M in Unusual Call Activity as Stock Trades Near 52-Week Highs

By TrendSpider Editor

Merck & Company, Inc. is drawing attention from options traders today, with three unusual call contracts generating a combined $1,920,100 in total premium as of Monday, September 14, 2026. All three contracts are in-the-money, suggesting traders are positioning for continued upside rather than specu

Merck Sees $1.9M in Unusual Call Activity as Stock Trades Near 52-Week Highs

Merck & Company, Inc. is drawing attention from options traders today, with three unusual call contracts generating a combined $1,920,100 in total premium as of Monday, September 14, 2026. All three contracts are in-the-money, suggesting traders are positioning for continued upside rather than speculative long-shot bets. MRK shares are currently trading at $144.86, up 0.64% on the session, and sitting comfortably above the midpoint of its 52-week range of $77.58 to $156.92.

Key Drivers of the MRK Stock Move

The forward setup for MRK looks constructive on the options flow alone, but the clustering of short-dated, in-the-money calls expiring this week suggests this may be more about capturing intrinsic value or hedging existing short positions than a pure directional bet on a breakout. The stock has staged a significant recovery from its 52-week low of $77.58, more than doubling to the current $144.86 level, which means latecomers face an asymmetric risk-reward equation. Traders should watch how the stock behaves into Friday's expiration, as the $135 and $125 strikes will both be meaningful levels to monitor for pinning or acceleration through the close of the week.

MRK Unusual Options Activity

All three contracts are calls, and no put activity was flagged in today's unusual flow. The zero put count alongside three call contracts reflects a decisively one-sided, bullish options tape for MRK today. The 200% open interest ratio on the January 2027 $40 call is particularly notable, as it indicates the new volume is double the existing open interest, a hallmark of fresh positioning rather than a close-out trade.

MRK Seasonality

Mid-September has historically been a period of elevated volatility across the broader market as quarterly rebalancing and options expiration converge, which may partly explain the concentration of activity in the September 18 contracts. For large-cap pharmaceutical names like Merck, the back half of September has occasionally seen increased institutional repositioning ahead of fourth-quarter outlooks and conference season.

MRK Relative Performance

MRK's 0.64% gain today reflects measured but steady momentum, with the stock trading at $144.86 against a 52-week range of $77.58 to $156.92. The current price places MRK approximately 7.7% below its 52-week high, suggesting room to run toward prior highs if buying pressure continues. The stock's recovery from its 52-week low represents substantial appreciation that has outpaced many large-cap peers in the healthcare sector over the same period.

More on MRK

Latest Market News